LBT Innovations (ASX:LBT) Inks $700,000 Deal with NovaCina for APAS Technology

Australian medical tech company LBT Innovations secured a contract with NovaCina, a Perth-based contract development and manufacturing organisation, for its APAS Independence instrument paired with APAS PharmaQC software.

The deal encompasses a five-year package, including annual software licenses, maintenance, and support services, totalling over $700,000.

Delivery and installation of the APAS instrument at NovaCina's manufacturing facility are scheduled for June.